遇见数据集

Supplementary materials for A Phase III Study to Compare Efficacy and Safety of BAT2206 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis

收藏
Mendeley Data2026-04-09 收录
官方服务:

资源简介:

Supplementary tables

提供机构:
Zhejiang University
二维码
社区交流群
二维码
科研交流群
商业服务